EU regulator finds possible link between AstraZeneca vaccine and rare blood clots but says benefits outweigh risks

Apr 7, 2021 | INVESTING

The EU’s medicines regulator on Wednesday said blood clots should be listed as a rare side effect of the AstraZeneca jab but the benefits continue to outweigh risks, as several countries battle fresh virus surges amid vaccine shortfalls.A number of nations have suspended the use of AstraZeneca’s vaccine for younger populations after it was earlier banned outright in several places over blood clot scares.Britain on Wednesday said that people under the age of 30 should choose alternatives to the…

Read More

Pin It on Pinterest